Suivre
Marc Brisson
Marc Brisson
Full Professor, Laval University
Adresse e-mail validée de uresp.ulaval.ca - Page d'accueil
Titre
Citée par
Citée par
Année
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
M Drolet, É Bénard, MC Boily, H Ali, L Baandrup, H Bauer, S Beddows, ...
The Lancet infectious diseases 15 (5), 565-580, 2015
8442015
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
M Drolet, É Bénard, N Pérez, M Brisson, H Ali, MC Boily, V Baldo, ...
The Lancet 394 (10197), 497-509, 2019
8392019
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
M Brisson, JJ Kim, K Canfell, M Drolet, G Gingras, EA Burger, D Martin, ...
The Lancet 395 (10224), 575-590, 2020
5922020
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
T Malagón, M Drolet, MC Boily, EL Franco, M Jit, J Brisson, M Brisson
The Lancet infectious diseases 12 (10), 781-789, 2012
5412012
Epidemiology of varicella zoster virus infection in Canada and the United Kingdom
M Brisson, WJ Edmunds, B Law, NJ Gay, R Walld, M Brownell, LL Roos, ...
Epidemiology & Infection 127 (2), 305-314, 2001
4982001
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries
K Canfell, JJ Kim, M Brisson, A Keane, KT Simms, M Caruana, EA Burger, ...
The Lancet 395 (10224), 591-603, 2020
4382020
Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox
M Brisson, NJ Gay, WJ Edmunds, NJ Andrews
Vaccine 20 (19-20), 2500-2507, 2002
4242002
The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study
M Drolet, M Brisson, KE Schmader, MJ Levin, R Johnson, MN Oxman, ...
Cmaj 182 (16), 1731-1736, 2010
3472010
Modelling the impact of immunization on the epidemiology of varicella zoster virus
M Brisson, WJ Edmunds, NJ Gay, B Law, G De Serres
Epidemiology & Infection 125 (3), 651-669, 2000
3192000
Economic evaluation of vaccination programs: the impact of herd-immunity
M Brisson, WJ Edmunds
Medical Decision Making 23 (1), 76-82, 2003
3102003
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic …
M Brisson, É Bénard, M Drolet, JA Bogaards, I Baussano, S Vänskä, M Jit, ...
The Lancet Public Health 1 (1), e8-e17, 2016
3042016
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
M Jit, M Brisson, A Portnoy, R Hutubessy
The Lancet Global health 2 (7), e406-e414, 2014
2872014
The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales
WJ Edmunds, M Brisson, JD Rose
Vaccine 19 (23-24), 3076-3090, 2001
2342001
Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force-5
R Pitman, D Fisman, GS Zaric, M Postma, M Kretzschmar, J Edmunds, ...
Value in health 15 (6), 828-834, 2012
2292012
The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada
M Brisson, N Van de Velde, P De Wals, MC Boily
Vaccine 25 (29), 5399-5408, 2007
2202007
Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study
X Li, C Mukandavire, ZM Cucunubá, SE Londono, K Abbas, HE Clapham, ...
The Lancet 397 (10272), 398-408, 2021
1892021
Epidemiology of varicella‐zoster virus in England and Wales
M Brisson, WJ Edmunds
Journal of medical virology 70 (S1), S9-S14, 2003
1852003
Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
JM Pellissier, M Brisson, MJ Levin
Vaccine 25 (49), 8326-8337, 2007
1792007
Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide
J Bilcke, P Beutels, M Brisson, M Jit
Medical Decision Making 31 (4), 675-692, 2011
1782011
Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model–based analysis
N Van de Velde, MC Boily, M Drolet, EL Franco, MH Mayrand, EV Kliewer, ...
Journal of the National Cancer Institute 104 (22), 1712-1723, 2012
1702012
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20